Figure 2. Cumulative rates of pancreatic cancer according to different durations of statin use during the follow-up period in the type 2 diabetes cohort.
1. Mei-Jyh Chen, Yu-Tse Tsan, Jyh-Ming Liou, Yi-Chia Lee, Ming-Shiang Wu, Han-Mo Chiu, Hsiu-Po Wang, and Pau-Chung Chen. (2016). Statins and the risk of pancreatic cancer in Type 2 diabetic patients-A population-based cohort study. International Journal of Cancer. 138(3):594-603. DOI: 10.1002/ijc.29813.
2. Mei-Jyh Chen, Yu-Tse Tsan, and Pau-Chung Chen. (2016). Authors’ reply to: Statins and the risk of pancreatic cancer in type 2 diabetic patients: Immortal time bias in survival analysis? International Journal of Cancer. 139(5):1182-1183. DOI: 10.1002/ijc.30140.
Dr. Mei-Jyh Chen
Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital
Professor Pau-Chung Chen
Institute of Occupational Medicine and Industry Hygiene, College of Public Health